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Aim. To compare the quality of life (QoL) in the first postoperative year after elective endovascular abdominal aortic
aneurysm repair (EVAR) and open repair (OR) in a randomised study.
Methods. In the Dutch Randomised Endovascular Aneurysm Management (DREAM) trial, patients are randomly
allocated to EVAR or OR. QoL questionnaires (SF-36 and EuroQoL-5D) were sent to all patients preoperatively (PREOP)
and at five time points in the first postoperative year (3W, 6W, 3M, 6M and 12M). Between November 1999 and August
2002, 153 patients (141 male; 12 female) were randomised (78 EVAR and 75 OR; one crossover from OR to EVAR). The
EuroQoL-5D scores and the eight domains of the SF-36 for the two groups were compared using the Mann–Whitney test.
Changes over time were analysed using the Wilcoxon sign test.
Results. There were no statistically significant differences in baseline characteristics (age, gender and SVS risk factors). The
preoperative QoL scores of the study group were similar to the QoL scores of the general population of the same age. After 3W
the OR group showed a significant decrease on the EuroQol-5D (p ¼ 0.022) and in six of the eight SF-36 domains. The
EVAR group also showed a significant decrease on the EuroQol-5D (p ¼ 0.004) and in 5 of the 8 domains of the SF-36. At
6W the EuroQol-5D had recovered to baseline in the OR group and the decreased domains of the SF-36 had partially
recovered. In the EVAR group the EuroQol-5D and three of the five decreased SF-36 domains, had returned to baseline. From
6M on, the OR group reported a significantly higher score on the EuroQoL-5D than the EVAR group (p ¼ 0.045 (6M) and
p ¼ 0.001 (12M)).
Conclusion. In the early postoperative period there is a small, yet significant QoL advantage for EVAR compared to OR. At
6 months and beyond, patients reported better QoL after OR than after EVAR.
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Background
Endovascular abdominal aortic aneurysm repair
(EVAR) is less invasive than open repair (OR).
However, EVAR may be complicated by endoleaks
and endograft failure leading to a reintervention rate
of about 10% per annum.1 – 4 Furthermore, the long-
term outcome of EVAR is still not known. The
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relatively high reintervention rate in combination with
the uncertainty about the durability of EVAR might
result in a reduced quality of life (QoL). Several studies
have been published on this subject, however, until
now there have been no randomised studies compar-
ing the impact of EVAR and OR on the QoL.5 – 8 The
aim of our study was to compare QoL in the first
postoperative year after elective EVAR and OR in a
randomised study.
Patients and Methods
In the Dutch Randomised Endovascular Aneurysm
Management (DREAM) trial, patients suitable for both
treatments are randomly allocated to EVAR or OR. The
study design has been described in detail elsewhere.9
The Institutional Review Board of all participating
hospitals approved the study and informed consent
was obtained from each patient. The study was funded
by the Dutch Health Insurance Council (OG68).
Between November 1999 and August 2002, 153
patients (141 male; 12 female, mean age 70 years
(range 53–85 yrs, SD 6.9) were treated (78 EVAR and
75 OR; one crossover from OR to EVAR). Health
related quality of life was measured using the
standardised Medical Outcomes Study Short-form
36-item survey (SF-36) and the EuroQol-5D.10 – 12 The
SF-36 includes a multi-item scale that assesses eight
health domains:
1. limitations in physical activities because of health
problems (PF),
2. limitations in social activities because of physical or
emotional problems (SF),
3. limitations in usual role activities because of
physical health problems (RP),
4. bodily pain (BP),
5. general mental health (MH) (physiological distress
and well-being),
6. limitations in usual role activities because of
emotional problems (RE),
7. vitality (VT) (energy and fatigue),
8. general health perceptions (GH).
For each domain a score can be calculated ranging
from 0 to 100, with higher scores indicating a better
QoL (0 ¼ death, 100 perfect health). The EuroQol-5D
consists of five questions, defining health in terms of
mobility, self-care, usual activities, pain/discomfort
and anxiety/depression. Again, higher scores indicate
a better QoL.
The QoL questionnaires (SF-36 and EuroQol-5D)
were sent to all patients preoperatively and at five time
points in the first postoperative year (3 weeks, 6 weeks,
3 months, 6 months and 12 months). If the question-
naire was not filled out completely, questions were
completed with a telephone call.
Statistical Analysis
Statistical analysis was performed using SPSS version
11.0 (SPSS Inc., Chicago, IL, USA). Mean (SD) scores at
baseline (preoperative values) and postoperatively
were calculated for both groups. Baseline character-
istics (age, gender, SVS risk score13) of both trial arms
were compared with student’s T-test and Chi-square.
Baseline scores were compared with the scores of
general Dutch population of the same age.11 A p-value
of less than 0.05 was considered significant. Changes
over time were analysed for each trial arm using the
Wilcoxon sign test.
Changes in time in QoL scores were also calculated
relative to the preoperative level. At each time point,
the absolute and relative scores on the domains of
SF-36 and the EuroQoL-5D for the trial arms were
compared using the non-parametric Mann–Whitney
test.
To assess responsiveness, a standardised response
mean (effect-size) was calculated, i.e. the difference in
mean scores at baseline and postoperatively divided
by the standard deviation of the baseline score.14 An
effect-size of 0.2 is defined as small, one of 0.5 as
moderate and one of 0.8 or greater as large.15
Results
There were no differences in baseline characteristics
(age, gender and SVS risk factors) between EVAR and
OR (Table 1). The comparison of the preoperative QoL
scores of the study group with the scores of the age
matched Dutch population is presented in Table 2. The
QoL scores of the study group tended to be lower
for several domains, but large standard deviations
preclude valid statistical conclusions.
With respect to the morbidity and mortality there
were no losses to follow-up in the first year. Cumu-
lative survival at 12 months in the OR group was 89%
(SD 3.5%) and 95% (SD 2.6%) in the EVAR group
(p ¼ 0:21; logrank). In addition, the cumulative event
free survival at 12 months was 72% (SD 5.2%) in the
OR group versus 76% (SD 5.0%) in the EVAR group
(p ¼ 0:49; logrank).
The preoperative questionnaire response rate was
83% in the OR group and 97% in the EVAR group
(p ¼ 0:003; Chi-square). The postoperative response
rates for OR and EVAR were 73% versus 97%
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ðp ¼ 0:049Þ at 3 weeks, 75% versus 86% ðp ¼ 0:08Þ at
6 weeks, 87% versus 93% ðp ¼ 0:238Þ at 3 months, 87%
versus 95% ðp ¼ 0:097Þ at 6 months and 91% versus
94% ðp ¼ 0:346Þ at 12 months.
The changes on the domains of SF-36 (health
profiles) over time for each trial arm are shown in
Fig. 1. At the 3 weeks time point the OR group showed
a significant decrease compared to baseline level on six
of the eight SF-36 domains (PF p , 0:001; SF p , 0:001;
RP p , 0:001; RE p ¼ 0:006, VT p , 0:001; BP p ¼ 0:001,
Wilcoxon sign test). The EVAR group showed a
significant decrease on five of the domains of the
SF-36 (PF p , 0:001; SF p , 0:001; RP p ¼ 0:001; VT
p ¼ 0:006; BP p ¼ 0:01; Wilcoxon sign test). Six weeks
after surgery the OR group showed a partial recovery
on all the impaired domains, significantly for the PF,
SF and VT (6W versus 3W, p , 0:001; p , 0:001 and
Table 1. Baseline characteristics.
OR ðNÞ EVAR ðNÞ Missing ðNÞ
Male:female 69/7 72/5
Mean age (yrs) (range) 69.9 (53–85) 70.5 (55–82)
Diabetes 1
None (0) 72 71
Adult onset, diet (1) 3 4
Adult onset, insuline (2) 1 1
Tobacco use 2
None or .10 yrs age (0) 39 28
Not current, ,10 yrs ago (1) 13 17
Current, ,1 pack/day (2) 15 28
Current, .1 pack/day (3) 8 3
Hyperlipidemia 10
Normal levels (0) 37 44
Mild elevation, diet (1) 7 8
Strict dietary control (2) 1 1
Dietary þ drug control (3) 24 21
Hypertension 2
None (0) 40 35
Single drug therapy (1) 23 27
2 Drug therapy (2) 11 11
. 2 Drugs or uncontrolled (3) 2 2
Carotid disease 1
No symptoms (0) 67 67
Asymptomatic, but disease (1) 4 1
TIA or temporary stroke (2) 3 5
Stroke/neurologic deficit (3) 2 3
Cardiac status 1
Asymptomatic, normal ECG (0) 39 44
Asymptomatic, remote or occult MI (1) 33 25
Stable AP, drug compensated CHF (2) 4 7
Renal status 2
No renal disease (0) 70 69
Creatinine , 210 mmol/L (1) 5 6
Pulmonary status 2
Asymptomatic, PFT . 80% of predicted (0) 64 51
Asymptomatic, PFT 65–80% of predicted (1) 9 21
PFT 35–65% of predicted (2) 3 3
Table 2. SF-36 scores (mean 1 SD) of the Dutch population of
61–70 years, the OR and EVAR group.
Domain Population (SD)* OR (SD) EVAR (SD)
PF 71.7 (25.6) 70.8 (22.9) 70.1 (22.8)
SF 82.0 (24.6) 73.6 (22.8) 70.0 (25.3)
RP 67.3 (40.9) 57.4 (44.3) 52.9 (45.5)
RE 81.1 (35.0) 64.8 (44.2) 60.7 (44.0)
MH 76.9 (17.9) 68.8 (19.8) 68.0 (20.1)
VT 67.7 (19.6) 60.4 (20.5) 60.0 (23.3)
BP 70.5 (24.6) 73.1 (27.1) 71.8 (28.2)
GH 61.7 (20.2) 60.8 (18.6) 62.9 (18.5)
PF, physical function; SF, social functioning; RP, role-physical; RE,
role-emotional; MH, mental health; VT, vitality; BP, bodily pain; GH,
general health.
*Aaronson NK, et al.: validation, and norming of the Dutch language
version of the SF-36 Health Survey in community and chronic
disease populations. J Clin Epidemiol 1998; 51(11):1055–1068.
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p ¼ 0:004; respectively, Wilcoxon sign test). In the
EVAR group three (SF, RE, VT) of the five decreased
domains had returned to baseline, and PF and RP
showed a partial but significant recovery (6W versus
3W, p , 0:001 and p ¼ 0:048; respectively, Wilcoxon
sign test). Three months after surgery both groups
recovered at least to baseline level on all domains.
There was a significant increase in both groups on MH
(3M vs preop. p , 0:001 for OR and p ¼ 0:005 for
EVAR, Wilcoxon sign test) and in the OR group also on
Fig. 1. Changes on the domains of SF-36 over time for OR and EVAR. On the x-axis the eight domains of the SF-36, on the
y-axis the scores. PF, physical function; SF, social functioning; RP, role-physical; RE, role-emotional; MH, mental health; VT,
vitality; BP, bodily pain; GH, general health.
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the GH (p ¼ 0:004; Wilcoxon sign test). One year after
surgery, the OR group showed a significantly higher
QoL than the baseline level on three of the eight SF-36
domains (SF , 0.001, RE p ¼ 0:002 and MH p , 0:001).
All other domains were still at baseline level. At this
time point, the EVAR group showed a significant
increase on RE ðp ¼ 0:021Þ and MH ðp ¼ 0:001Þ: More-
over, a significant decrease compared to the baseline
level was reported on PF ðp ¼ 0:033Þ:
The EuroQol-5D scores for groups showed a
significant decrease 3 weeks after surgery (OR
p ¼ 0:022; EVAR p ¼ 0:004; Wilcoxon sign test). At
the 6 week time interval, both groups showed a
completely recovery to baseline on EuroQol-5D. For
the EVAR group EuroQol-5D scores remained at
baseline level from 3 months on. The OR group was
still at baseline level at 3 months, but the EuroQoL-5D
showed a significant increase compared to the baseline
level at the 6 and 12 months time interval (p ¼ 0:028
and p ¼ 0:002; respectively, Wilcoxon sign test).
Comparing the absolute scores at the 3 weeks time
interval between the trial arms, the OR group had
significantly lower scores on PF, SF and RP (p ¼ 0:026;
p ¼ 0:027 and p , 0:001; respectively, Mann–Whitney
test). The RP score in the OR was still significantly
lower than in the EVAR group 6 weeks postoperatively
(p ¼ 0:034; Mann – Whitney test). Comparing the
absolute scores at 12 months between the two trial
arms, the OR scored significantly higher than the
EVAR group on PF ðp ¼ 0:016Þ; SF ðp ¼ 0; 017Þ; RE
ðp ¼ 0:024Þ; BP ðp ¼ 0:025Þ and GH ðp ¼ 0:024Þ: The
EuroQol-5D scores did not differ significantly between
OR and EVAR until 6 months postoperatively. How-
ever, from that time point on the OR group showed
significantly higher scores than the EVAR group
(p ¼ 0:045 and p ¼ 0:001; 6M and 12M, respectively,
Mann–Whitney test).
The effect-sizes for both groups are shown in
Table 3. The impact of the intervention was larger for
the OR group than for the EVAR group. At 3 weeks, in
the OR group the effect-sizes were classified as severe
on three domains (PF, SF, RP), moderate on three
domains (RE, VT, BP), no effect on MH, and a slight
improvement on GH. In the EVAR group, no severe
impact was measured, a moderate effect on four
domains (PF, SF, RP, BP), a mild effect on three
domains (RE, VT, GH) and a small improvement on
MH. The impact on the EuroQol-5D was moderate in
both groups at 3 weeks. Six weeks postoperatively, the
impact of the intervention has decreased but is still
severe on the RP, moderate on PF, SF and BP in the OR
group, whereas the impact on the EVAR group has
decreased to mild. On year after surgery, a positive
impact is seen in the OR group on all domains and the
EuroQol-5D. In the EVAR group this positive impact is
also seen, except for PF, GH and EuroQol-5D.
Discussion
Although quality of life is a complex entity that is
difficult to define, patient satisfaction weighs heavily
in the decision which treatment is best. In contrast to
the number of studies published about the medical
differences between EVAR over OR, there have been
only a handful of studies examining QoL. To our
knowledge this is the first randomised study on QoL
after EVAR and OR.
This study has shown that both EVAR and OR has
an impact on the QoL, particularly in the first 3 weeks
after the intervention, causing deterioration on almost
all domains and also the EuroQol-5D. With regard
to the physical domains, this decrease in QoL is
significantly more pronounced in the OR group than
in the EVAR group. Because there were no differences
in survival rates or event free survival in the first year,
this can be explained by the differences in invasiveness
of the OR compared to EVAR. This was also shown in
Table 3. Effect sizes compared to baseline level p-values; Wilcoxon sign test.
3 weeks 6 weeks 3 months 6 months 12 months
OR EVAR p-value OR EVAR p-value OR EVAR p-value OR EVAR p-value OR EVAR p-value
PF 21.2 20.7 0.008 20.5 20.3 0.300 0.1 20.1 0.230 0.1 20.2 0.039 0.1 20.2 0.070
SF 21.4 20.7 0.003 20.5 20.2 0.216 0.2 0.2 0.987 0.3 0.2 0.684 0.6 0.2 0.038
RP 21.1 20.5 0.013 20.8 20.4 0.099 20.2 0.0 0.302 0.1 0.2 0.906 0.3 0.2 0.484
RE 20.5 20.2 0.448 20.2 0.1 0.288 0.1 0.2 0.876 0.3 0.4 0.883 0.5 0.3 0.154
MH 0.0 0.1 0.671 0.2 0.2 0.714 0.4 0.3 0.704 0.5 0.3 0.151 0.5 0.4 0.487
VT 20.7 20.3 0.169 20.3 20.2 0.211 0.1 0.0 0.649 0.3 0.1 0.222 0.2 0.0 0.382
BP 20.6 20.6 0.836 20.5 20.1 0.095 0.1 0.1 0.809 0.3 0.1 0.297 0.3 0.1 0.209
GH 0.1 20.1 0.167 0.1 0.0 0.348 0.3 20.1 0.010 0.3 20.1 0.005 0.4 20.1 0.004
EuroQol-5D 20.5 20.6 0.857 20.1 20.3 0.426 0.2 0.0 0.646 0.3 20.2 0.005 0.5 20.1 0.004
PF, physical function; SF, social functioning; RP, role-physical; RE, role-emotional; MH, mental health; VT, vitality; BP, bodily pain; GH,
general health.
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the study of Aquino et al., although the first post-
operative measurement took place 1 week after the
operation.6 At the fourth week measurement, all
scores in their EVAR group had returned to the
preoperative level. At our second measurement
(6 weeks postoperatively) all decreased scores, except
RP and BP in the OR group, showed a partial but not
complete recovery.
Lloyd et al. compared the baseline level with one
postoperative measurement only, 6 months after
surgery.5 They found a significant deterioration in
the domains of physical function in both groups. In
our study and also in the study of Aquino, all patients
had at least returned to their baseline level at that time
point. An explanation for this different finding could
be that Lloyd performed a paired analysis for all
patients without discriminating between EVAR and
OR. In addition, their endovascular group consisted of
high-risk patients who were not suitable for conven-
tional repair. On the other hand, they also compared
the OR group with the EVAR group and found no
significant differences. The differently chosen time
intervals between these studies make comparison
difficult and also emphasises the point that little is
known about the changes over time.
One weakness of our study could be the difference
in the preoperative and the 3-week postoperative
response rate between the EVAR and OR group. We do
not have an appropriate explanation for the difference
in preoperative response rate. Except that for the early
postoperative period it could be that more patients
were too ill to fill out the questionnaires in the OR
group. Even so, this would support our conclusion
that there is an advantage of EVAR in the early
postoperative period. Another weakness of this study
is that the analysis is not longitudinal. However,
missing data is inherent to a QoL study. Providing
only longitudinal data would introduce a selection
bias also.
In our study, the mental function showed no
decrease postoperatively and even increased over
time reaching significantly higher scores than the
baseline in both groups. Perkins et al. also reported
this.16 A possible explanation for this is the relief of the
anxiety following repair of the aneurysm.
The intensive surveillance of EVAR did not seem to
result in an impaired QoL, contrary to suggestions
made in the literature.6,17,18 Current results cannot be
explained by differences in intensity of surveillance as
follow-up protocols for OR and EVAR were the same.
After 3 months, both groups had regained at least
their preoperative level on all domains. It is remark-
able the OR group scored significantly better than
the EVAR group at 1 year postoperatively on five of the
eight domains and the EuroQol-5D, whereas the
groups had similar scores preoperatively. This seems
to indicate there is an advantage in QoL of the OR
group over the EVAR group, 1 year postoperatively.
As elective repair of an AAA is treatment of an
asymptomatic condition, it is by definition hard to
actually improve the QoL. As the preoperative QoL in
our study group was lower on several domains of the
SF-36 than the scores of the general population, this
may indicate that the knowledge of having a poten-
tially life-threatening disease does have an impact on
the QoL. The increase in QoL 1 year after AAA repair
has been described in other QoL studies, mostly in the
OR group, but also in studies on QoL after other major
abdominal surgery.8,16,18,19 An explanation may be
that people experience a relatively better QoL after a
period of severe illness or major surgery.
Conclusion
In the early postoperative period there is a small yet
significant QoL advantage of EVAR compared to OR.
At 6 months and beyond, patients reported a better
QoL after OR than after EVAR.
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